155 related articles for article (PubMed ID: 31570431)
21. Biological activity of DC-CIK cells and its effect against leukemia cells in vitro.
Wei XC; Zhai XH; Han XR; Yang DD; Zhao WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1150-3. PubMed ID: 18928615
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus.
Pfirrmann V; Oelsner S; Rettinger E; Huenecke S; Bonig H; Merker M; Wels WS; Cinatl J; Schubert R; Klingebiel T; Bader P
Cytotherapy; 2015 Aug; 17(8):1139-51. PubMed ID: 26072027
[TBL] [Abstract][Full Text] [Related]
23. Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells.
Pan Y; Chiu YH; Chiu SC; Cho DY; Lee LM; Wen YC; Whang-Peng J; Hsiao CH; Shih PH
Anticancer Res; 2020 Jul; 40(7):3865-3872. PubMed ID: 32620626
[TBL] [Abstract][Full Text] [Related]
24. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].
Ge W; Li CH; Zhang W; Han Q; Deng WM; Chen L; You SG; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):277-80. PubMed ID: 15182535
[TBL] [Abstract][Full Text] [Related]
25. Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells.
Cheng XY; Li JL
Genet Mol Res; 2015 Oct; 14(4):13208-14. PubMed ID: 26535634
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway.
Iudicone P; Fioravanti D; Cicchetti E; Zizzari IG; Pandolfi A; Scocchera R; Fazzina R; Pierelli L
Hum Immunol; 2016 Dec; 77(12):1239-1247. PubMed ID: 27615504
[TBL] [Abstract][Full Text] [Related]
27. An additional CD28 costimulatory signal enhances proliferation and cytotoxicity of murine T cell-derived CIK cell.
Timalsena S; Pluangnooch P; Wongkajornsilp A; Soontrapa K
Asian Pac J Allergy Immunol; 2017 Jun; 35(2):67-74. PubMed ID: 27543727
[TBL] [Abstract][Full Text] [Related]
28. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
[TBL] [Abstract][Full Text] [Related]
29. Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.
Mesiano G; Zini R; Montagner G; Bianchi N; Manfredini R; Chillemi A; Aglietta M; Grignani G; Lampronti I; Fiorino E; Malavasi F; Sangiolo D; Gambari R; Ferrari D
Mol Med; 2017 Oct; 23():235-246. PubMed ID: 28805233
[TBL] [Abstract][Full Text] [Related]
30. Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
Oelsner S; Wagner J; Friede ME; Pfirrmann V; Genßler S; Rettinger E; Buchholz CJ; Pfeifer H; Schubert R; Ottmann OG; Ullrich E; Bader P; Wels WS
Int J Cancer; 2016 Oct; 139(8):1799-809. PubMed ID: 27253354
[TBL] [Abstract][Full Text] [Related]
31. Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment.
Hsiao CH; Chiu YH; Chiu SC; Cho DY; Lee LM; Wen YC; Li JJ; Shih PH
J Vis Exp; 2020 Jan; (155):. PubMed ID: 32065149
[TBL] [Abstract][Full Text] [Related]
32. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].
DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806
[TBL] [Abstract][Full Text] [Related]
33. [Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].
Yang XJ; Huang JA; Lei W; Zhu YB; Zhang XG
Ai Zheng; 2006 Nov; 25(11):1329-33. PubMed ID: 17094896
[TBL] [Abstract][Full Text] [Related]
34. CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo.
Wang Y; Bo J; Dai HR; Lu XC; Lv HY; Yang B; Wang T; Han WD
Exp Hematol; 2013 Mar; 41(3):241-52.e3. PubMed ID: 23123634
[TBL] [Abstract][Full Text] [Related]
35. Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo.
Wang J; He M; Shi W; Sha H; Feng J; Wang S; Wang Y
Cancer Invest; 2009 Mar; 27(3):244-50. PubMed ID: 19194830
[TBL] [Abstract][Full Text] [Related]
36. Cytokine-induced killer cells co-cultured with non-cell derived targeting peptide-loaded dendritic cells induce a specific antitumor response.
Liu C; Cui X; Zhou D; Li C; Zhao M; Jin Y; Ding C; Zhu Y
Cancer Biol Ther; 2019; 20(5):720-728. PubMed ID: 30777479
[TBL] [Abstract][Full Text] [Related]
37. Multiple cytotoxic factors involved in IL-21 enhanced antitumor function of CIK cells signaled through STAT-3 and STAT5b pathways.
Rajbhandary S; Zhao MF; Zhao N; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM
Asian Pac J Cancer Prev; 2013; 14(10):5825-31. PubMed ID: 24289584
[TBL] [Abstract][Full Text] [Related]
38. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
39. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells.
Kim YJ; Lim J; Kang JS; Kim HM; Lee HK; Ryu HS; Kim JY; Hong JT; Kim Y; Han SB
Arch Pharm Res; 2010 Nov; 33(11):1789-95. PubMed ID: 21116782
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
Cappel C; Huenecke S; Suemmerer A; Erben S; Rettinger E; Pfirrmann V; Heinze A; Zimmermann O; Klingebiel T; Ullrich E; Bader P; Bremm M
Pediatr Blood Cancer; 2016 Dec; 63(12):2230-2239. PubMed ID: 27433920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]